Representational Image
New Delhi: An Indian pharma company now finds itself in the eye of a storm as Uzbekistan claimed that 18 children have died in the country after consuming medicines manufactured by Noida-based Marion Biotech.
As per reports on a local Uzbek news website, the government said that 21 kids were hospitalised with acute respiratory diseases – a side-effect of consuming the cough syrup Dok-One Max, which Marion Biotech allegedly manufactures. 18 of these children have since died.
Uzbek health ministry claimed that the primary laboratory studies have shown the presence of ethylene glycol in the syrup. It is the same chemical that is a common contaminant in pharma products made without adequate safeguards.
India on Tuesday launched an inquiry into a Noida-based drugs manufacturer after the deaths of 18 children in Uzbekistan were linked to the firm. A criminal probe has also been initiated by the State Security Service of the Central Asian nation.
New Delhi: Hafiz Talha Saeed, the son of 28/11 Mumbai attack mastermind, Lashkar-e-Taiba (LeT) terrorist… Read More
New Delhi: Parineeti Chopra's conspicuous absence from wedding festivities of cousin Siddharth Chopra, brother of Priyanka… Read More
Mumbai: InterGlobe Aviation Ltd, the parent company of IndiGo, has been hit with penalties totalling… Read More
New Delhi: Four years after his separation from Melinda French in 2021, Microsoft co-founder Bill… Read More
Hyderabad: The Naga Chaitanya and Sai Pallavi starrer ‘Thandel’, presented by Allu Arjun’s father Allu… Read More
Bhubaneswar: The Biju Janata Dal (BJD) on Thursday shot off a letter to University Grants… Read More
This website uses cookies.
